Healthcare entity

Irene

Person

market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Gilead Sciences, the most common co-covered peer. The tracked stories average 3 original sources each. Irene appears in 1 tracked Healthcare story from August 13, 2026.

Last mentioned: Aug 13, 2026

Entity pulse

Recent coverage · Irene

1 story
7 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Irene

market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Gilead Sciences, the most common co-covered peer. The tracked stories average 3 original sources each. Irene appears in 1 tracked Healthcare story from August 13, 2026.

Stories tracked
1
Sources per story
3

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Irene. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. NPR report details mixed rollout reviews in Uganda

    A syndicated story from Kalisizo, Uganda highlights participant Irene's experience, the drug's six-month protection, and ongoing implementation challenges.

  2. PURPOSE 1 and PURPOSE 2 deliver unprecedented efficacy

    An independent monitoring committee concluded lenacapavir was so effective that the randomized phase of both trials was halted early.

Stories mentioning Irene 1

Irene is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.